Choroidal Neovascularization Secondary to Angioid Streaks

Angioid streaks (AS) are characterized by pathological changes at the level of the Bruch membrane. The manifestations are usually bilateral. Patients may be asymptomatic unless the macula is involved. The main vision-threatening complication of AS is choroidal neovascularization (CNV) which develops in more than 2/3 of cases. The natural course of CNV associated with AS has a poor prognosis if left untreated. Several treatment methods have been proposed up to date. Laser photocoagulation, photodynamic therapy (PDT), transpupillary thermotherapy, photothrombosis with indocyanine green, and surgical therapy have been done in these cases. Nowadays, intravitreal anti-VEGF injections are widely used in the treatments of CNV secondary to AS.

2008 ◽  
Vol 71 (3) ◽  
pp. 311-315 ◽  
Author(s):  
Fernando Korn Malerbi ◽  
Sheau Jiun Huang ◽  
Fabio Bom Aggio ◽  
Edenilson Carvalho Jr. ◽  
Pedro Paulo Bonomo ◽  
...  

2003 ◽  
Vol 13 (5) ◽  
pp. 453-460 ◽  
Author(s):  
F. Cardillo Piccolino ◽  
C.M. Eandi ◽  
L. Ventre ◽  
R.C. Rigault De La Longrais ◽  
F.M. Grignolo

Purpose To evaluate the effectiveness of low power transpupillary thermotherapy (TTT) in treating juxtafoveal recurrent choroidal neovascularization (CNV) after laser photocoagulation in patients with age-related macular degeneration (ARMD). Methods Eight eyes of eight patients with ARMD and juxtafoveal recurrent CNV were treated with low power TTT, delivered using an 810-nm diode laser with 350 mW, 2.0 mm spot, and 1-minute duration. Visual acuity (VA) ranged from 20/100 to 20/50. Treatment effect was evaluated by fluorescein angiography, indocyanine green angiography, and VA measurements (Early Treatment Diabetic Retinopathy Study) at 1-week, 2-week, and monthly follow-up visits. Results NO retinal damage was visible ophthalmoscopically during treatment. At the first follow-up visit, seven eyes had obliteration of CNV and one eye required a second TTT application. VA was unchanged in six eyes, improved in one eye, and worsened in one eye. Recurrences occurred in all eyes between 1 and 7 months after TTT and were treated with photodynamic therapy (PDT). More than two PDT treatments were performed in each eye in the year after recurrence. Conclusions LOW power TTT is as able to close juxtafoveal recurrent CNV as is high power conventional laser photocoagulation but does not prevent recurrences. Further intervention with TTT in order to treat recurrences is under investigation.


2005 ◽  
Vol 15 (1) ◽  
pp. 69-73 ◽  
Author(s):  
I.D. Ladas ◽  
I. Georgalas ◽  
A.A. Rouvas ◽  
S. Gotsis ◽  
D.A. Karagiannis ◽  
...  

Retina ◽  
1997 ◽  
Vol 17 (1) ◽  
pp. 12-16 ◽  
Author(s):  
ALFREDO PECK ◽  
PAOLA AVANZA ◽  
LAURA GALLI ◽  
ROSARIO BRANCATO

Sign in / Sign up

Export Citation Format

Share Document